The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
American Medical News' 55-year publishing run will come to a close this year, the AMA, its publisher, said today.
The CEO's unexpected departure is part of the health information brand's latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
Allergan's 2013 outlook scores points with at least one analyst, Amgen is laying off 160 staff, and Wiley renews a publishing relationship.
The most effective journal ads of the year included executions for Pradaxa, Humira and Conceptus' Essure Procedure, according to the Doctors' Choice Study.
Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found Advair, Spiriva and Mirena to be tops in their categories with doctors.
The alumna of Bayer's crop, medical and diabetes units is taking on the title of group worldwide chairman, which comes with oversight of the global supply chain, IT and the troubled consumer unit.
Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.
Could an online quiz be the future of continuing medical education? In a twist on the "edu-gaming" phenomenon, Cleveland Clinic and physician site MDLinx aim to answer that question with The Smartest Doc, a daily one-minute quiz that aims to keep doctors up to date on the medical literature by appealing to their competitive spirit.
Sermo is searching for a CEO and a medical advisory board since the physician online community's founder, Dr. Daniel Palestrant, and chief medical officer, Dr. Adam Sharp, left in November to launch a new startup called Par8o.
Over the last four years, drugmakers have slashed support for samples as they rethink what once was an essential part of their marketing mix.
Merck's Global Health Innovation Fund (GHIF) is investing up to $17 million in Physicians Interactive, a company that develops digital products for doctors such as e-sampling and interactive education programs.
Ipsen announced plans to reorganize its North American commercial operation by relocating the head office from California to New Jersey and hiring about 100 employees.
Well before the FDA revoked Avastin's approval in breast cancer, Roche's Genentech unit deeply cut the professional media plan for the drug, the company said.
Pri-Med founder John Mooney and his former management team have returned to the firm, which is under new ownership following M|C Holding's sale of Pri-Med's US assets to Canadian event and media producer Diversified Business Communications.
Wolters Kluwer reached an agreement to sell its pharma-related marketing and publishing services unit to Springer Science+Business Media, the firms said today.
New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta?
Publicis Healthcare Communications Group named Anders Ekman managing director of Saatchi & Saatchi Health Communications New York, the flagship professional healthcare agency of the Saatchi brand.
Double the number of MDs used Google (87%) for professional research online as the next most-used search options (WebMD and PubMed, each at 43%), data from a recent survey show.
Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the "Bad Ad" program.
For all the talk of e-detailing and digitizing the sales force, a plurality of international healthcare professionals would rather get info about new treatments from flesh-and-blood reps than through any other channel, a survey found.
Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation?
Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call.
Forest Labs will acquire Clinical Data for $1.2 billion, and expand its primary care sales forces in preparation for the launch of Viibryd (vilazodone HCI), executives said in a call this morning.
A large survey of sales reps found that knowledge of evidence-based medicine and clinical practice guidelines, as well as information related to managing the business aspects of a healthcare practice, are the two best ways to get a foot in the door with physicians
Sunovion Pharmaceuticals is targeting 22,000 psychiatrists in the US, with a sales force of 336 reps, in support of Latuda, an atypical antipsychotic for the treatment of schizophrenia. Psychiatrists can also request samples and track delivery online.
Progenics announced that it will hand over commercial duties on Relistor, a subcutaneous injection for opioid-induced constipation, to Salix Pharmaceuticals, beginning in April. Financial terms include a $60 million upfront payment to Progenics, and another potential $290 million in development and sales-based milestone payments.
Sales reps armed with an iPad can collect digital signatures for samples thanks to iRep, a physician detailing application set to launch in mid-February.
Merck and GSK are both increasing the number of sales reps operating in China, according to separate presentations given by the two companies. In both cases, added reps in emerging markets are helping to offset significant reductions in US sales forces, company executives said.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.